The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Levitina E.V.

GBOU VPO "Tiumenskaia gosudarstvennaia meditsinskaia akademiia", Tiumen'

Traĭkhil' A.M.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza, Tiumen'

Zakateĭ I.G.

Okruzhnaia klinicheskaia bol'nitsa, Salekhard

Bazhukhin D.V.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza, Tiumen'

Sivertsev M.Iu.

Poliklinika konsul'tativno-diagnosticheskaia im. E.M. Niginskogo, Tiumen'

Smirnova N.F.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki lechebnogo fakul'teta GOU VPO "Rossiĭskiĭ nauchno-issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova" Minzdrava Rossii

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

The first Russian experience of using natalizumab in the treatment of relapsing-remitting multiple sclerosis in children

Authors:

Sivertseva S.A., Levitina E.V., Traĭkhil' A.M., Zakateĭ I.G., Bazhukhin D.V., Sivertsev M.Iu., Smirnova N.F., Boĭko A.N.

More about the authors

Read: 1335 times


To cite this article:

Sivertseva SA, Levitina EV, Traĭkhil' AM, et al. . The first Russian experience of using natalizumab in the treatment of relapsing-remitting multiple sclerosis in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(10‑2):92‑98.

Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
Resu­lts of 4 years of therapy with divo­zilimab in patients with rela­psing multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):51-59
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.